U.S. Health System Transformation | Center for Health and Biosciences | Commentary

Chemotherapy Drug Shortages in the U.S. — The Recurring Nightmare

Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.

Hagop M. Kantarjian, Vivian Ho March 13, 2014

Drug Policy | Commentary

Prioritizing Public Safety Over Applying Outdated Drug Policy

By Rehman Bhalesha

Jury nullification — when a jury disagrees with the law and acquits a defendant they believe to be…

February 20, 2014

Drug Policy | Commentary

Ceasefire in the War on Marijuana in Texas? Trial by Jury and Jury Nullification

By Gilbert G. Garcia

Jury nullification — when a jury disagrees with the law and acquits a defendant they believe to be…

February 19, 2014

Drug Policy | Commentary

Baker Institute Viewpoints: Jury Nullification

In this installment of Baker Institute Viewpoints, experts discuss the question, "What does jury nullification of marijuana cases in Texas indicate about the possibility of marijuana legalization?"

William Martin February 19, 2014

Drug Policy | Commentary

Jury Nullification: Local Option

Jury nullification — when a jury disagrees with the law and acquits a defendant they believe to be guilty — has a long…

William Martin February 18, 2014

Drug Policy | Commentary

Can Jurors Hasten the Legalization of Cannabis?

By Clay S. Conrad

Jury nullification — when a jury disagrees with the law and acquits a defendant they believe to be…

February 17, 2014

U.S. Health System Transformation | Center for Health and Biosciences | Issue Brief

Deciphering the Hippocratic Oath in the 21st Century

Many contemporary medical ethicists dismiss the centuries-old Hippocratic Oath as outdated because of the enormous scientific, social, economic, and political changes since Hippocrates' time. Health policy scholar Hagop Kantarjian makes a case for its relevance.

Hagop M. Kantarjian January 10, 2014

Science and Technology Policy | Research Paper

Science and Technology: Ensuring America's Science Future

The United States should assign a particularly high priority on science and technology over the next four years, especially for federal support of research.

Neal F. Lane, Kirstin R.W. Matthews March 8, 2013

Drug Policy | Center for the U.S. and Mexico | Journal

Mexico Drug Policy and Security Review 2012

Introduction

With a new year and a new administration in Mexico we can expect continuity in substantive policy and…

Nathan P. Jones January 11, 2013

A scientist picks up test tubes from a rack.

Science and Technology Policy | Research Paper

C60 — A Model for the Future

A Civic Scientist Précis on Robert F. Curl Jr., Ph.D., Sir Harold Kroto, Ph.D., and the late Richard Smalley, Ph.D.

Kirstin R.W. Matthews, Neal F. Lane October 12, 2010

Research Library

Introduction